Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2018

Open Access 01-12-2018 | Research

Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma

Authors: Michael J Nathenson, Constance M Barysauskas, Robert A Nathenson, William F Regine, Nader Hanna, Edward Sausville

Published in: World Journal of Surgical Oncology | Issue 1/2018

Login to get access

Abstract

Background

Retroperitoneal soft tissue sarcomas (STS) include a number of histologies but are rare, with approximately 3000 cases in the USA per year. Retroperitoneal STS have a high incidence of local and distant recurrence. The purpose of this study was to review the University of Maryland Medical Center’s (UMMC) treatment experience of retroperitoneal STS, where the patient population served represents a diverse socioeconomic and ethnic catchment.

Methods

IRB approval was obtained. We constructed a de-identified database of patients diagnosed with retroperitoneal liposarcomas (LPS) or leiomyosarcomas (LMS) treated at UMMC between 2000 and 2013. A total of 49 patients (Pts) with retroperitoneal STS met our eligibility criteria. Kaplan-Meier plots were used to graphically portray progression-free survival (PFS) and overall survival (OS). The log-rank test was used to compare time-to-event distributions.

Results

The median OS for all patients (Pts) was 6.3 years, and the 2-year OS rate was 81%. The median PFS for all Pts was 1.8 years, and the 2-year PFS rate was 45%. There was no difference in OS and PFS among LMS and LPS patients; the median OS for LMS was 3.8 years vs. LPS 6.4 years (p = 0.33), and the median PFS for LMS was 1.2 years vs. LPS 2.5 years (p = 0.28). There was a significant difference between histology and race (p = 0.001). LPS were primarily Caucasian 86% vs. 14% black, whereas LMS were primarily black 52% vs. 33% Caucasian. OS was influenced by functional status, gender, American Joint Committee on Cancer (AJCC) stage, grade, histology, tumor size, and extent of resection. PFS was influenced by AJCC stage, grade, and extent of resection. Neither adjuvant chemotherapy (1 Pt) nor neoadjuvant/adjuvant radiation therapy (18 Pts) influenced OS or PFS. There was a non-significant difference that Pts who could undergo resection of local recurrence had improved 2-year OS, with 100% LMS and LPS compared to 2-year OS of 71% (LMS) and 78% (LPS) not undergoing resection of local recurrence.

Conclusions

This study suggests a higher incidence of leiomyosarcoma in the African-American population. This study confirms the prognostic importance of grade, tumor size, AJCC stage, histology, and extent of resection in patient outcomes, at a large substantially diverse academic medical center. Future research into the biological features of liposarcoma and leiomyosarcoma Pts imparting these characteristics will be important to define.
Literature
1.
go back to reference Siegel R, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.CrossRef Siegel R, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.CrossRef
3.
go back to reference Crago AM, Singer S. Soft tissue sarcoma. In: Ashley S, Cance W, Chen H, Jurkovich G, Napolitano L, Pemberton J, Riall T, Swanson S, Valentine J, editors. ACS surgery: principles and practice. 7th ed. New York: Decker Intellectual Properties Inc; 2011. Crago AM, Singer S. Soft tissue sarcoma. In: Ashley S, Cance W, Chen H, Jurkovich G, Napolitano L, Pemberton J, Riall T, Swanson S, Valentine J, editors. ACS surgery: principles and practice. 7th ed. New York: Decker Intellectual Properties Inc; 2011.
4.
go back to reference Singer S, Tap WD, Crago AM, O’Sullivan B. Soft tissue sarcoma. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 10th ed. Philadelphia: Wolters Kluwer Health; 2015. p. 1253–91. Singer S, Tap WD, Crago AM, O’Sullivan B. Soft tissue sarcoma. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 10th ed. Philadelphia: Wolters Kluwer Health; 2015. p. 1253–91.
5.
go back to reference Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS Working Group. Ann Surg. 2016;263:1002–9.CrossRef Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS Working Group. Ann Surg. 2016;263:1002–9.CrossRef
6.
go back to reference Callegaro D, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas. Expert Rev Anticancer Ther. 2015;15:553–67.CrossRef Callegaro D, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas. Expert Rev Anticancer Ther. 2015;15:553–67.CrossRef
7.
go back to reference Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21(14):2719–25.CrossRef Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21(14):2719–25.CrossRef
8.
go back to reference Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016;263:1002–9.CrossRef Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016;263:1002–9.CrossRef
9.
go back to reference Raut CP, Miceli R, Strauss D, et al. External validation of a multi-insitutional retroperitoneal sarcoma nomogram. Cancer. 2016;122(9):1417–24.CrossRef Raut CP, Miceli R, Strauss D, et al. External validation of a multi-insitutional retroperitoneal sarcoma nomogram. Cancer. 2016;122(9):1417–24.CrossRef
10.
go back to reference Coindre JM, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869–77.CrossRef Coindre JM, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869–77.CrossRef
11.
go back to reference Coindre JM, Terrier P, Gulliou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. Cancer. 2001;91:1914–26.CrossRef Coindre JM, Terrier P, Gulliou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. Cancer. 2001;91:1914–26.CrossRef
12.
go back to reference PWT P, DHY L, Wooduff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–89.CrossRef PWT P, DHY L, Wooduff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–89.CrossRef
13.
go back to reference Zagars G, Ballo M, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy. Cancer. 2003;97:2530–43.CrossRef Zagars G, Ballo M, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy. Cancer. 2003;97:2530–43.CrossRef
14.
go back to reference Gronchi A, Miceli R, Shurell E, et al. Outcome predication in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–55.CrossRef Gronchi A, Miceli R, Shurell E, et al. Outcome predication in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–55.CrossRef
15.
go back to reference Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcomas. J Clin Oncol. 1997;15(1):350–62.CrossRef Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcomas. J Clin Oncol. 1997;15(1):350–62.CrossRef
16.
go back to reference Jensn M, Kaae S, Madsen EH, et al. Histopatholigcal grading in soft-tissue tumors: relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scandinavica. 1983;91A:145. Jensn M, Kaae S, Madsen EH, et al. Histopatholigcal grading in soft-tissue tumors: relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scandinavica. 1983;91A:145.
17.
go back to reference Callegaro D, Miceli R, Mariani L, et al. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer. 2017;123(5):2802–20.CrossRef Callegaro D, Miceli R, Mariani L, et al. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer. 2017;123(5):2802–20.CrossRef
18.
go back to reference Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18:1637–43.CrossRef Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18:1637–43.CrossRef
19.
go back to reference Stojadinovic A, Yeh A, Brennan MF. Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes. J Am Coll Surg. 2002;194:436–47.CrossRef Stojadinovic A, Yeh A, Brennan MF. Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes. J Am Coll Surg. 2002;194:436–47.CrossRef
20.
go back to reference Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma. Ann Surg. 2009;250:977–94.CrossRef Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma. Ann Surg. 2009;250:977–94.CrossRef
21.
go back to reference Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol. 2010;17:1481–4.CrossRef Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol. 2010;17:1481–4.CrossRef
22.
go back to reference Pisters PWT. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2008;27:6–8.CrossRef Pisters PWT. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2008;27:6–8.CrossRef
23.
go back to reference Crago AM. Extended surgical resection and histology in retroperito- neal sarcoma. Ann Surg Oncol. 2014;22:1401–3.CrossRef Crago AM. Extended surgical resection and histology in retroperito- neal sarcoma. Ann Surg Oncol. 2014;22:1401–3.CrossRef
24.
go back to reference Kirane A, Crago AM. The importance of surgical margins in retroperitoneal sarcoma. J Surg Oncol. 2015;113:270–6.CrossRef Kirane A, Crago AM. The importance of surgical margins in retroperitoneal sarcoma. J Surg Oncol. 2015;113:270–6.CrossRef
25.
go back to reference Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2008;27:24–30.CrossRef Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2008;27:24–30.CrossRef
26.
go back to reference Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.CrossRef Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.CrossRef
27.
go back to reference Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate- grade soft tissue sarcomas. Ann Oncol. 2011;23:1067–73.CrossRef Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate- grade soft tissue sarcomas. Ann Oncol. 2011;23:1067–73.CrossRef
28.
go back to reference Markhede G, Angerwall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982;49:1721–33.CrossRef Markhede G, Angerwall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982;49:1721–33.CrossRef
29.
go back to reference O’Sullivan B, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–41.CrossRef O’Sullivan B, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–41.CrossRef
30.
go back to reference Péchoux CL, Muscat E, Baey C, et al. Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? Ann Oncol. 2013;24:832–7.CrossRef Péchoux CL, Muscat E, Baey C, et al. Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? Ann Oncol. 2013;24:832–7.CrossRef
31.
go back to reference Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults. Meta-analysis of individual data. The Lancet. 1997;350(9092):1647–54.CrossRef Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults. Meta-analysis of individual data. The Lancet. 1997;350(9092):1647–54.CrossRef
32.
go back to reference Pervaiz N, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–81.CrossRef Pervaiz N, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–81.CrossRef
33.
go back to reference MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcomas: a report from the Trans-Atlantic RPS Working Group. Cancer. 2017;123(11):1971–8.CrossRef MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcomas: a report from the Trans-Atlantic RPS Working Group. Cancer. 2017;123(11):1971–8.CrossRef
34.
go back to reference Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21:397–402.CrossRef Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21:397–402.CrossRef
35.
go back to reference Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg. 2016;263:593–600.CrossRef Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg. 2016;263:593–600.CrossRef
36.
go back to reference Soft Tissue Sarcoma in. Edge S, Byrd D, Compton C, (Eds.) AJCC staging manual. 7th ed. New York: Springer-Verlag; 2010. p. 143–64. Soft Tissue Sarcoma in. Edge S, Byrd D, Compton C, (Eds.) AJCC staging manual. 7th ed. New York: Springer-Verlag; 2010. p. 143–64.
37.
go back to reference Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.CrossRef Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.CrossRef
38.
go back to reference Kaplan EL, Meier P. Nonparametric estimator from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan EL, Meier P. Nonparametric estimator from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
39.
go back to reference Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;60:163–70. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;60:163–70.
40.
go back to reference van Houdt WJ, Zaidi S, Messiou C, et al. Treatment of retroperitoneal sarcoma: current standards and new developments. Curr Opin Oncol. 2017;29(4):260–7.CrossRef van Houdt WJ, Zaidi S, Messiou C, et al. Treatment of retroperitoneal sarcoma: current standards and new developments. Curr Opin Oncol. 2017;29(4):260–7.CrossRef
41.
go back to reference Vijay A, Ram L. Retroperitoneal liposarcoma: a comprehensive review. Am J Clin Oncol. 2015;38(2):213–9.CrossRef Vijay A, Ram L. Retroperitoneal liposarcoma: a comprehensive review. Am J Clin Oncol. 2015;38(2):213–9.CrossRef
42.
go back to reference Alamanda VK, Song Y, Schwartz HS, et al. Racial disparities in extremity soft-tissue sarcoma outcomes: a nationwide analysis. Am J Clin Oncol. 2015;38(6):595–9.CrossRef Alamanda VK, Song Y, Schwartz HS, et al. Racial disparities in extremity soft-tissue sarcoma outcomes: a nationwide analysis. Am J Clin Oncol. 2015;38(6):595–9.CrossRef
43.
go back to reference Lazarides AL, Visgauss JD, Nussbuam DP, et al. Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities. BMC Cancer. 2018;18(1):488.CrossRef Lazarides AL, Visgauss JD, Nussbuam DP, et al. Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities. BMC Cancer. 2018;18(1):488.CrossRef
44.
go back to reference Datta J, Ecker BL, Neuwirth MG. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol. 2017;26(2):117–24.CrossRef Datta J, Ecker BL, Neuwirth MG. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol. 2017;26(2):117–24.CrossRef
45.
go back to reference Hass RL, Baldini EH, Chung PW, et al. Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol. 2017;22 Epub ahead of print. Hass RL, Baldini EH, Chung PW, et al. Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol. 2017;22 Epub ahead of print.
46.
go back to reference Fairweather M, Gonzalez RJ, Strauss D, Raut CP. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018;8 Epub ahead of print. Fairweather M, Gonzalez RJ, Strauss D, Raut CP. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018;8 Epub ahead of print.
Metadata
Title
Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma
Authors
Michael J Nathenson
Constance M Barysauskas
Robert A Nathenson
William F Regine
Nader Hanna
Edward Sausville
Publication date
01-12-2018
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1505-4

Other articles of this Issue 1/2018

World Journal of Surgical Oncology 1/2018 Go to the issue